Stories
November 13, 2026 by sciencemediacentre.org
expert reaction to a study looking at the effects of e-cigarette use on pulmonary function
A new pilot study suggesting that prolonged vaping may affect lung function has drawn criticism from independent experts over significant methodological limitations.
The research involved just 22 participants, lacked a control group and could not fully account for previous smoking. Experts also noted that key findings were not statistically significant after adjustment for multiple comparisons.
Although further research into the respiratory effects of vaping remains important, the responses highlight the need for larger, well-controlled studies before drawing conclusions about long-term harm. Scientific accuracy is essential to informed tobacco harm reduction and responsible risk communication.
11.80% of the adult population are current smokers. There are approximately 6.7 million current smokers in United Kingdom 13.60% of men are current smokers but only 10.10% of women.
SOURCE: GSTHR
November 13, 2026 by vapingpost.com
Quitting smoking: vaping helps without support, but twice as well with it
A UK randomised controlled trial involving 1,170 smokers found that providing e-cigarettes without behavioural support helped more participants quit smoking than automated cessation advice alone.
After six months, 11.3% of those receiving a vape kit had stopped smoking, compared with 6.4% receiving support emails. Adding telephone counselling increased the quit rate to 21.1%.
The findings highlight the potential of vaping as an accessible smoking cessation tool, while demonstrating how additional behavioural support can further improve outcomes. Combining practical alternatives with personalised assistance could help more adults move away from combustible tobacco.
11.80% of the adult population are current smokers. There are approximately 6.7 million current smokers in United Kingdom 13.60% of men are current smokers but only 10.10% of women.
SOURCE: GSTHR
November 13, 2026 by clearingtheair.eu
EU Commission declines to confirm December timetable for nicotine rules
The European Commission has declined to confirm whether its proposed revision of the Tobacco Products Directive will be published in December, amid reports of a possible delay until January 2027.
The uncertainty follows reported concerns over the proposal's impact assessment, while Health Commissioner Olivér Várhelyi continues to face criticism for suggesting that newer nicotine products carry the same risks as conventional tobacco.
The developments raise important questions about scientific accuracy and transparency in EU tobacco policy. Future regulation should recognise differences in product risk and consider the role of smoke-free alternatives in reducing smoking-related harm.
November 12, 2026 by environewsnigeria.com
Africa's tobacco policy failure: Illicit trade grows, harm reduction stalls
Africa's tobacco control challenges extend beyond smoking prevalence, with illicit tobacco trade expanding and access to safer nicotine alternatives remaining limited in many countries.
Restrictive policies, uneven enforcement and insufficient smoking cessation support have raised concerns about the effectiveness of existing approaches. These challenges highlight the importance of combining stronger action against illicit markets with evidence-based tobacco harm reduction.
A more comprehensive strategy should consider affordability, consumer behaviour and risk-proportionate regulation to help reduce smoking-related disease across the continent.
November 12, 2026 by clearingtheair.eu
French Senate blocks nicotine vape starter
A proposal to ban nicotine vape starter packs in France has been blocked on procedural grounds, preventing a new restriction on products used by adults seeking alternatives to cigarettes.
The amendment would have prohibited selling vaping devices together with nicotine-containing e-liquids, potentially making it less convenient for smokers to begin switching.
Although the proposal did not proceed, similar restrictions could still be introduced. The debate highlights the importance of preserving access to effective smoking cessation tools, particularly as Cochrane evidence shows that nicotine e-cigarettes can help more people quit smoking than traditional nicotine replacement therapies.
28.30% of the adult population are current smokers. There are approximately 15.7 million current smokers in France.
SOURCE: GSTHR
November 12, 2026 by clivebates.com
Evidence sent to the WHO review of nicotine
The WHO's upcoming review of nicotine could have significant implications for the future of tobacco harm reduction.
Following Palau's proposal to bring nicotine under the UN Convention on Psychotropic Substances, a detailed evidence briefing has been submitted to the WHO Expert Committee on Drug Dependence ahead of its critical review in October 2027.
The submission calls for a broader assessment of nicotine science, dependence and public health policy, emphasising the importance of distinguishing nicotine use from the harms of combustible tobacco. International regulatory decisions should consider the potential consequences for smoking cessation and access to lower-risk alternatives.
November 10, 2026 by clearingtheair.eu
77% of Quebec vapers still use banned flavours three years on
Quebec’s flavour ban has not eliminated demand for flavoured vaping products. Three years after its introduction, 77% of vapers still report using flavours covered by the restrictions, with fruit flavours remaining particularly popular.
The findings raise questions about the effectiveness of flavour bans and their potential to shift consumers towards informal or illicit markets. Tobacco harm reduction policies should consider real-world behaviour and preserve access to regulated alternatives for adults seeking to move away from cigarettes.
10.60% of the adult population are current smokers. There are approximately 3.5 million current smokers in Canada 13.10% of men are current smokers but only 8.10% of women.
SOURCE: GSTHR
November 10, 2026 by substack.com
When the Evidence Finds Nothing: The Missing E-Cigarette Marketing Story
A study examining digital marketing exposure among 31 Aboriginal adults in Australia detected no e-cigarette advertising and very little tobacco promotion, despite including both categories in its assessment of unhealthy product marketing.
Most recorded exposure involved food, gambling and alcohol. However, the small sample and limited observation period mean the findings cannot establish broader population trends.
The analysis raises questions about drawing regulatory conclusions from preliminary evidence. Effective tobacco harm reduction policy requires distinguishing between observed findings, potential risks and assumptions about nicotine marketing.
8.20% of the adult population are current smokers. There are approximately 1.8 million current smokers in Australia 9.50% of men are current smokers but only 6.90% of women.
SOURCE: GSTHR
November 10, 2026 by medium.com
How People Perceive Risks
People do not always assess risk according to scientific evidence. Psychological research shows that unfamiliar, invisible and uncontrollable threats often generate greater fear than well-known dangers, even when their actual risks are lower.
This helps explain why newer nicotine products can be perceived as more dangerous than cigarettes, despite substantially reducing exposure to many harmful toxicants.
Understanding how people perceive risk is essential to tobacco harm reduction. Public health communication must address both the scientific evidence and the psychological factors shaping consumer decisions.
November 09, 2026 by pouchforum.eu
FDA Recognizes Nicotine Harm Reduction as Brussels Questions Science
The US FDA has authorised 24 additional nicotine pouch products, bringing the total to 67, while explicitly recognising their potential to help adults switch away from more harmful tobacco products.
The decision contrasts with the European Commission's position, which continues to question whether smoke-free nicotine alternatives reduce health risks compared with cigarettes, despite evidence of substantially lower toxicant exposure.
The differing approaches highlight the importance of incorporating relative risk into tobacco regulation. Scientific uncertainty about long-term effects should be acknowledged without overlooking the potential contribution of smoke-free products to tobacco harm reduction.
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
- Page 1 of 388